| scholarly article | Q13442814 |
| P2093 | author name string | Barnes PJ | |
| P2860 | cites work | A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. | Q24531049 |
| Histone acetylation and deacetylation: importance in inflammatory lung diseases | Q28237379 | ||
| Theophylline: new perspectives for an old drug | Q35080486 | ||
| Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. | Q35682823 | ||
| Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline | Q36225408 | ||
| Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression | Q36227904 | ||
| Theophylline in chronic obstructive pulmonary disease: new horizons | Q36305327 | ||
| Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. | Q36402442 | ||
| Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration | Q40580109 | ||
| Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease. | Q43997156 | ||
| Effect of low-dose theophylline on airway inflammation in COPD. | Q44925207 | ||
| Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease. | Q53675896 | ||
| Decreased histone deacetylase activity in chronic obstructive pulmonary disease. | Q54664094 | ||
| Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways | Q74139318 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 742-744 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Theophylline for COPD. | |
| P478 | volume | 61 |
| Q91796595 | 2-Cl-C.OXT-A stimulates contraction through the suppression of phosphodiesterase activity in human induced pluripotent stem cell-derived cardiac organoids |
| Q38190849 | Chronic obstructive pulmonary disease: clinical review and update on consensus guidelines |
| Q38821694 | Effect of roflumilast on airway remodelling in a murine model of chronic asthma |
| Q34768928 | Effects in cigarette smoke stimulated bronchial epithelial cells of a corticosteroid entrapped into nanostructured lipid carriers. |
| Q26771819 | Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease |
| Q47592522 | Evaluating Suspension Formulations of Theophylline Cocrystals With Artificial Sweeteners |
| Q42036960 | Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy |
| Q37200994 | It's about time--directing our attention toward modifying the course of COPD. |
| Q37791058 | Methylxanthines and Inflammatory Cells |
| Q42873072 | Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential |
| Q41845309 | Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler |
| Q37532557 | New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy |
| Q37017344 | Pharmacological treatment of chronic obstructive pulmonary disease |
| Q39020015 | Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations. |
| Q56909272 | Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma |
| Q37754942 | Salmeterol/fluticasone propionate combination in the treatment of COPD. |
| Q37512163 | Steroid Resistant CD8+CD28null NKT-Like Pro-inflammatory Cytotoxic Cells in Chronic Obstructive Pulmonary Disease |
| Q26740559 | Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks |
| Q90214194 | Systemic Inflammation in the Genesis of Frailty and Sarcopenia: An Overview of the Preventative and Therapeutic Role of Exercise and the Potential for Drug Treatments |
| Q36956720 | Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease |
| Q35230530 | The Study of Efficacy, Tolerability and Safety of Theophylline Given Along with Formoterol Plus Budesonide in COPD. |
| Q38087697 | The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations |
| Q34910141 | The efficacy and safety of cilomilast in COPD. |
| Q46908580 | Theophylline and its metabolites produce a stimulating cholinergic effect on the small intestine and a nonadrenergic noncholinergic relaxing effect on the colon: a comparative study in the rabbit intestine |
| Q33664235 | Theophylline. |
| Q38578596 | Updates in the management of stable chronic obstructive pulmonary disease |
| Q50795103 | [Alveolar epithelial cell injury as an etiopathogenic factor in pulmonary fibrosis]. |
Search more.